AddicottM.A., YangL.L., PeifferA.M., BurnettL.R., BurdetteJ.H., ChenM.Y., HayasakaS., KraftR.A., MaldjianJ.A., LaurientiP.J.2009. The effect of daily caffeine use on cerebral blood flow: how much caffeine can we tolerate? Hum. Brain Mapping, 30,10:3102–3114.
2.
ArmstrongL.E., PumerantzA.C., RotiM.W., JudelsonD.A., WatsonG., DiasJ.C., SokmenB., CasaD.J., MareshC.M., LiebermanH., KelloggM.2005. Fluid, electrolyte, and renal indices of hydration during 11 days of controlled caffeine consumption. Int. J. Sports Nutr. Exerc. Metab., 15,3:252–265.
BerglundB., HemmingssonP.1982. Effects of caffeine ingestion on exercise performance at low and high altitudes in cross-country skiers. Int. J. Sports Med.4:234–236.
5.
BurkeL.M.2008. Caffeine and sports performance. Appl. Physiol. Nutr. Metab., 33,6:1319–1334.
6.
ChapmanR.F., StagerJ.M.2008. Caffeine stimulates ventilation in athletes with exercise-induced hypoxemia. Med. Sci. Sports Exerc., 40,6:1080–1086.
7.
ChardonK., BachV., TelliezF., CardotV., TourneuxP., LekeA., LibertJ.-P.2004. Effect of caffeine on peripheral chemoreceptor activity in premature neonates: interaction with sleep stages. J. Appl. Physiol., 96,6:2161–2166.
8.
ChenY., ParrishT.B.2009. Caffeine's effects on cerebrovascular reactivity and coupling between cerebral blood flow and oxygen metabolism. Neuroimage., 44,3:647–652.
9.
ComerA.M., PerryC.M., FiggittD.P.2001. Caffeine citrate: a review of its use in apnoea of prematurity. Paediatr. Drugs., 3,1:61–79.
10.
DaganY., DoljanskyJ.T.2006. Cognitive performance during sustained wakefulness: a low dose of caffeine is equally effective as modafinil in alleviating the nocturnal decline. Chronobiol. Int., 23,5:973–983.
11.
DemuraS., YamadaT., TerasawaN.2007. Effect of coffee ingestion on physiological responses and ratings of perceived exertion during submaximal endurance exercise. Percept. Motor Skills., 105,3, Pt. 2:1109–1116.
12.
DillD.B.et al.1940. Benzedrine sulphate (amphetamine) and acute anoxia. J. Aviat. Med., 11,4.
13.
D'UrzoA.D., JhiradR., JenneH., AvendanoM.A., RubinsteinI., D'CostaM., GoldsteinR.S.1990. Effect of caffeine on ventilatory responses to hypercapnia, hypoxia, and exercise in humans. J. Appl. Physiol., 68,1:322–328.
14.
FischerR., LangS.M., LeitlM., ThiereM., SteinerU., HuberR.M.2004. Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude. Eur. Respir. J., 23,1:47–52.
FulcoC.S., RockP.B., TradL.A., RoseM.S., ForteV.A.Jr., YoungP.M., CymermanA.1994. Effect of caffeine on submaximal exercise performance at altitude. Aviat. Space Environ. Med., 65,6:539–545.
17.
GrahamT.E.2001. Caffeine and exercise: metabolism, endurance and performance. Sports Med., 31,11:785–807.
18.
HaaseC.G., BeckaM., KuhlmannJ., WensingG.2005. Influences of caffeine, acetazolamide and cognitive stimulation on cerebral blood flow velocities. Prog. Neuropsychopharmacol. Biol. Psychiatry., 29,4:549–556.
19.
HanM.E., KimH.J., LeeY.S., KimD.H., ChoiJ.T., PanC.S., YoonS., BaekS.Y., KimB.S., KimJ.B., OhS.O.2009. Regulation of cerebrospinal fluid production by caffeine consumption. BMC Neurosci., 10:110.
20.
HuckN.O., McBrideS.A., KendallA.P., GrugleN.L., KillgoreW.D.2008. The effects of modafinil, caffeine, and dextroamphetamine on judgments of simple versus complex emotional expressions following sleep deprivation. Int. J. Neurosci., 118,4:487–502.
21.
JürgensG., ChristensenH.R., BrøsenK., SonneJ., LoftS., OlsenN.V.2002. Acute hypoxia and cytochrome P450-mediated hepatic drug metabolism in humans. Clin. Pharmacol. Ther., 71,4:214–220.
22.
KamimoriG.H., HoytR.W., EddingtonN.D., YoungP.M., DurkotM.J., ForteV.A., BrunhartA.E., LugoS., CymermanA.1995a. Effects of chronic hypoxia on the pharmacokinetics of caffeine and cardio-green in micro swine. Aviat. Space Environ. Med., 66,3:247–250.
23.
KamimoriG.H., EddingtonN.D., HoytR.W., FulcoC.S., LugoS., DurkotM.J., BrunhartA.E., CymermanA.1995b. Effects of altitude (4300 m) on the pharmacokinetics of caffeine and cardio-green in humans. Eur. J. Clin. Pharmacol., 48,2:167–170.
24.
KillgoreW.D., Kahn-GreeneE.T., GrugleN.L., KillgoreD.B., BalkinT.J.2009. Sustaining executive functions during sleep deprivation: a comparison of caffeine, dextroamphetamine, and modafinil Sleep, 32,2:205–216.
25.
KillgoreW.D., RuppT.L., GrugleN.L., ReichardtR.M., LipizziE.L., BalkinT.J.2008. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. J. Sleep Res., 17,3:309–321.
26.
KolataG.2009. Personal best: it's time to make a coffee run. New York Times, March25E1.
27.
KüpperT.E., StrohlK.P., HoeferM., GieselerU., NetzerC.M., NetzerN.C.2008. Low-dose theophylline reduces symptoms of acute mountain sickness. J. Travel Med., 15,5:307–314.
28.
LaniganC., HowesT.Q., BorzoneG.et al.1993. The effects of beta 2-agonists and caffeine on respiratory and limb muscle performance. Eur. Respir. J., 6:1192–1196.
McLellanT.M.2006. How does caffeine increase exercise capacity but decrease myocardial flow reserve? J. Am. Coll. Cardiol., 48,11:2355–2356author reply 2356.
31.
McLellanT.M., KamimoriG.H., VossD.M., TateC., SmithS.J.2007. Caffeine effects on physical and cognitive performance during sustained operations. Aviat. Space Environ. Med., 78,9:871–877.
32.
Millard-StaffordM.L., CuretonK.J., WingoJ.E., TrilkJ., WarrenG.L., BuyckxM.2007. Hydration during exercise in warm, humid conditions: effect of a caffeinated sports drink. Int. J. Sport Nutr. Exerc. Metab., 17,2:163–177.
NamdarM., SchepisT., KoepfliP., GaemperliO., SiegristP.T., GrathwohlR., ValentaI., DelaloyeR., KlaingutiM., WyssC.A., LüscherT.F., KaufmannP.A.2009. Caffeine impairs myocardial blood flow response to physical exercise in patients with coronary artery disease as well as in age-matched controls. PLoS One., 4,5:e5665.
35.
Rack-GomerA.L., LiauJ., LiuT.T.Caffeine reduces resting-state BOLD functional connectivity in the motor cortex. Neuroimage, 46,1:56–63.
36.
ScottD., RycroftJ.A., AspenJ., ChapmanC., BrownB.2004. The effect of drinking tea at high altitude on hydration status and mood. Eur. J. Appl. Physiol., 91,4:493–498.
37.
SigmonS.C., HerningR.I., BetterW., CadetJ.L., GriffithsR.R.2009. Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects. Psychopharmacology (Berlin)., 204,4:573–585.
38.
TarnopolskyM.A.2008. Effect of caffeine on the neuromuscular system-potential as an ergogenic aid. Appl. Physiol. Nutr. Metab., 33,6:1284–1289.
39.
ZhengX., LiQ., TangX., LiangS., ChenL., ZhangS., WangZ., GuoL., ZhangR., ZhuD.2008. Source of the elevation of Ca2+ evoked by 15-HETE in pulmonary arterial myocytes. Eur. J. Pharmacol., 601,1–3:16–22.